Ranolazine Dihydrochloride CAS: 95635-56-6

CAS NO: 95635-56-6
Ranolazine Dihydrochloride
Chemical Name: Ranolazine dihydrochloride
Molecular Formula: C24H35Cl2N3O4
Formula Weight: 500.46
CAS No.: 95635-56-6
Description Review
Description

Ranolazine Dihydrochloride (CAS: 95635-56-6) is a medication that is used to treat chronic angina, a condition that causes chest pain due to reduced blood flow to the heart. This drug works by blocking certain ion channels in the heart, which reduces the amount of oxygen needed by the heart muscle and helps to relieve angina symptoms.

Chemical name: (RS)-N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide dihydrochloride

Molecular formula: C24H33N3O4 · 2HCl

Formula weight: 500.44 g/mol

CAS No: 95635-56-6

Top ten keywords from Google and Synonyms:

  1. Chronic angina
  2. Chest pain
  3. Myocardial ischemia
  4. Antianginal drug
  5. Ion channel blocker
  6. Heart disease
  7. Ranexa
  8. Cardiac events
  9. Coronary artery disease
  10. Stable angina

Synonyms: (RS)-N-(2,6-Dimethylphenyl)-2-{[4-(2-hydroxy-3-(2-Methoxyphenoxy)propyl)piperazin-1-yl]acetyl}amide dihydrochloride, (RS)-2-[4-[2-Hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazinyl]-N-(2,6-dimethylphenyl)acetamide dihydrochloride, Ranexa dihydrochloride, CVT-303

Health benefits of Ranolazine Dihydrochloride:

Ranolazine Dihydrochloride is primarily used to treat chronic angina or chest pain caused by reduced blood flow to the heart. By blocking certain ion channels in the heart muscle, this drug can help reduce the amount of oxygen needed by the heart and relieve angina symptoms.

In addition to treating angina, Ranolazine Dihydrochloride has been shown to have potential health benefits for people with various heart conditions, such as myocardial ischemia, coronary artery disease, and stable angina. Studies have suggested that this medication may improve exercise tolerance and reduce the risk of cardiac events in these patients.

Potential effects of Ranolazine Dihydrochloride:

The primary effect of Ranolazine Dihydrochloride is to block certain ion channels in the heart muscle, which reduces the amount of oxygen needed by the heart and helps to relieve angina symptoms. In addition, studies have suggested that this drug may have other effects on the heart, including improving diastolic function, reducing the risk of ventricular arrhythmias, and increasing glucose uptake in the heart muscle.

Product mechanism:

Ranolazine Dihydrochloride works by blocking certain ion channels in the heart, specifically the late sodium channel. This channel plays a role in regulating the balance of sodium and calcium ions in the heart muscle, and blocking it can help reduce the amount of oxygen needed by the heart and relieve angina symptoms.

Safety:

Ranolazine Dihydrochloride is generally considered safe when taken as directed by a healthcare provider. However, like any medication, it does carry some risks and potential side effects. Before taking this medication, patients should discuss their medical history and any current medications with their healthcare provider to ensure that it is safe for them to take.

Side effects of Ranolazine Dihydrochloride:

Common side effects of Ranolazine Dihydrochloride include dizziness, headache, constipation, nausea, and vomiting. More serious side effects are rare, but may include allergic reactions, liver problems, and irregular heartbeats. Patients who experience any of these symptoms while taking this medication should contact their healthcare provider immediately.

Dosing information:

The recommended dose of Ranolazine Dihydrochloride varies depending on the patient's medical history and condition. It is important for patients to follow their healthcare provider's instructions regarding dosing and administration of this medication.

Conclusion:

Ranolazine Dihydrochloride is a medication that is used to treat chronic angina and other heart conditions. By blocking certain ion channels in the heart muscle, this drug can help reduce the amount of oxygen needed by the heart and relieve angina symptoms. While generally considered safe, this medication does carry some risks and potential side effects, so patients should discuss their medical history and any current medications with their healthcare provider before taking it. Overall, Ranolazine Dihydrochloride is an effective medication for treating chronic angina and has the potential to provide many health benefits for people with various heart conditions

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code